Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity

Journal of Interferon and Cytokine Research

Volumn 31, Issue 10, 2011, Pages 721-731

  Ganesh, Balaji B ^a   Bhattacharya, Palash ^a   Gopisetty, Anupama ^a   Prabhakar, Bellur S ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CHEMOKINE RECEPTOR CCR7; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; SECONDARY LYMPHOID TISSUE CHEMOKINE; THYROTROPIN RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROID DISEASE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HYPERTHYROIDISM; IMMUNE RESPONSE; MACROPHAGE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; TH1 CELL; TH17 CELL; TH2 CELL; THYROID DISEASE; THYROIDITIS;

AUTOANTIBODIES; AUTOIMMUNITY; CYTOKINES; GRAVES DISEASE; HASHIMOTO DISEASE; IMMUNITY, CELLULAR; RECEPTORS, THYROTROPIN; T-LYMPHOCYTES; THYROID GLAND;

EID: 80054708045     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0049     Document Type: Article

References (117)

1. Akinci B, Comlekci A, Yener S, Bayraktar F, Demir T, Ozcan MA, Yuksel F, Yesil S. 2008. Hashimoto's thyroiditis, but not treatment of hypothyroidism, is associated with altered TGF-beta1 levels. Arch Med Res 39(4):397-401.
2. Alimi E, Huang S, Brazillet MP, Charreire J. 1998. Experimental autoimmune thyroiditis (EAT) in mice lacking the IFN-gamma receptor gene. Eur J Immunol 28(1):201-208. (Pubitemid 28048291)
3. Batteux F, Trebeden H, Charreire J, Chiocchia G. 1999. Curative treatment of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for interleukin-10. Eur J Immunol 29(3):958-963. (Pubitemid 29119076)
4. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441(7090):235-238.
5. Bhattacharya P, Gopisetty A, Ganesh BB, Sheng JR, Prabhakar BS. 2011. GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms. J leukoc Biol 89(2):235-249.
6. Boehm U, Klamp T, Groot M, Howard JC. 1997. Cellular responses to interferon-gamma. Annu Rev Immunol 15:749-795.
7. Brahmachari S, Pahan K. 2009. Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxide. J Immunol 183(3): 2045-2058.
8. Braley-Mullen H, Sharp GC, Tang H, Chen K, Kyriakos M, Bickel JT. 1998. Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis. Am J Pathol 152(5):1347-1358. (Pubitemid 28221887)
9. Brown KD, Zurawski SM, Mosmann TR, Zurawski G. 1989. A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes. J Immunol 142(2):679-687. (Pubitemid 19039994)
10. Burchill MA, Yang J, Vogtenhuber C, Blazar BR, Farrar MA. 2007. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol 178(1):280-290. (Pubitemid 46033611)
11. Burnet M. 1959. Auto-immune disease. I. Modern immunologi-cal concepts. Br Med J 2(5153):645-650.
12. Caturegli P, Kimura H, Rocchi R, Rose NR. 2007. Autoimmune thyroid diseases. Curr Opin Rheumatol 19(1):44-48. (Pubitemid 44885726)
13. Chang JT, Segal BM, Nakanishi K, Okamura H, Shevach EM. 2000. The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta2 subunit. Eur J Immunol 30(4):1113-1119. (Pubitemid 30216228)
14. Cheatem D, Ganesh BB, Gangi E, Vasu C, Prabhakar BS. 2009. Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function. Clin Immunol 131(2):260-270.
15. Chen K, Wei Y, Sharp GC, Braley-Mullen H. 2007. Decreasing TNF-alpha results in less fibrosis and earlier resolution of granulomatous experimental autoimmune thyroiditis. J Leu-koc Biol 81(1):306-314. (Pubitemid 46021280)
16. Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, Kang HS, Ma L, Watowich SS, Jetten AM, Tian Q, and others. 2009. Critical regulation of early Th17 cell differentiation by inter-leukin-1 signaling. Immunity 30(4):576-587.
17. Crane IJ, Forrester JV. 2005. Th1 and Th2 lymphocytes in autoimmune disease. Crit Rev Immunol 25(2):75-102. (Pubitemid 40910583)
18. Davidson A, Diamond B. 2001. Autoimmune diseases. N Engl J Med 345(5):340-350.
19. de la Vega JR, Vilaplana JC, Biro A, Hammond L, Bottazzo GF, Mirakian R. 1998. IL-10 expression in thyroid glands: protective or harmful role against thyroid autoimmunity? Clin Exp Immunol 113(1):126-135. (Pubitemid 28329077)
20. de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174(4):915-924.
21. Dinarello CA. 2009. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519-550.
22. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 151(3):1224-1234. (Pubitemid 23219258)
23. Ding L, Shevach EM. 1992. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimula-tory function. J Immunol 148(10):3133-3139.
24. Dogan RN, Vasu C, Holterman MJ, Prabhakar BS. 2003. Absence of IL-4, and not suppression of the Th2 response, prevents development of experimental autoimmune Graves' disease. J Immunol 170(4):2195-2204. (Pubitemid 36197444)
25. Drugarin D, Negru S, Koreck A, Zosin I, Cristea C. 2000. The pattern of a T(H)1 cytokine in autoimmune thyroiditis. Immunol Lett 71(2):73-77. (Pubitemid 30089768)
26. Esquivel PS, Rose NR, Kong YC. 1977. Induction of autoim-munity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide. J Exp Med 145(5): 1250-1263. (Pubitemid 8105369)
27. Figueroa-Vega N, Alfonso-Perez M, Benedicto I, Sanchez-Madrid F, Gonzalez-Amaro R, Marazuela M. 2010. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocrinol Metabol 95(2):953-962.
28. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146(10):3444-3451.
29. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. 2005. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6(11):1142-1151. (Pubitemid 41541792)
30. Ganesh BB, Cheatem DM, Sheng JR, Vasu C, Prabhakar BS. 2009. GM-CSF-induced CD11c+CD8a-dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis. Int Immunol 21(3):269-282.
31. Gangi E, Vasu C, Cheatem D, Prabhakar BS. 2005. IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J Immunol 174(11):7006-7013. (Pubitemid 40705665)
32. Gaudreau S, Guindi C, Menard M, Besin G, Dupuis G, Amrani A. 2007. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells. J Immunol 179(6): 3638-3647.
33. Gorelik L, Constant S, Flavell RA. 2002. Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J Exp Med 195(11):1499-1505. (Pubitemid 34602827)
34. Gorelik L, Fields PE, Flavell RA. 2000. Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol 165(9):4773-4777.
35. Gorham JD, Guler ML, Fenoglio D, Gubler U, Murphy KM. 1998. Low dose TGF-beta attenuates IL-12 responsiveness in murine Th cells. J Immunol 161(4):1664-1670. (Pubitemid 28387582)
36. Green DR, Droin N, Pinkoski M. 2003. Activation-induced cell death in T cells. Immunol Rev 193:70-81. (Pubitemid 36688041)
37. Groux H, Cottrez F. 2003. The complex role of interleukin-10 in autoimmunity. J Autoimmunity 20(4):281-285. (Pubitemid 36677519)
38. Heath VL, Murphy EE, Crain C, Tomlinson MG, O'Garra A. 2000. TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression. Eur J Immunol 30(9):2639-2649.
39. Ho IC, Hodge MR, Rooney JW, Glimcher LH. 1996. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85(7):973-983. (Pubitemid 26231165)
40. Horie I, Abiru N, Nagayama Y, Kuriya G, Saitoh O, Ichikawa T, Iwakura Y, Eguchi K. 2009. T helper type 17 immune response plays an indispensable role for development of iodine-induced autoimmune thyroiditis in nonobese diabetic-H2h4 mice. Endocrinology 150(11):5135-5142.
41. Horie I, Abiru N, Saitoh O, Ichikawa T, Iwakura Y, Eguchi K, Nagayama Y. 2011. Distinct role of T helper Type 17 immune response for Graves' hyperthyroidism in mice with different genetic backgrounds. Autoimmunity 44(2):159-165.
42. Johnson VJ, Yucesoy B, Luster MI. 2005. Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol 116(4):851-858. (Pubitemid 41400551)
43. Kared H, Masson A, Adle-Biassette H, Bach JF, Chatenoud L, Zavala F. 2005. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasma-cytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells. Diabetes 54(1):78-84. (Pubitemid 40105097)
44. Kim CH. 2004. Chemokine-chemokine receptor network in immune cell trafficking. Current Drug Targets 4(4):343-361. (Pubitemid 39445433)
45. Klecha AJ, Barreiro Arcos ML, Frick L, Genaro AM, Cremaschi G. 2008. Immune-endocrine interactions in autoimmune thyroid diseases. Neuroimmunomodulation 15(1):68-75.
46. Kong YC, Morris GP, Brown NK, Yan Y, Flynn JC, David CS. 2009. Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function. J Autoimmunity 33(3-4):239-246.
47. Korn T, Bettelli E, Gao W, Awasthi A, Jager A, Strom TB, Oukka M, Kuchroo VK. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448(7152): 484-487. (Pubitemid 47123515)
48. Kroemer G, Hirsch F, Gonzalez-Garcia A, Martinez C. 1996. Differential involvement of Th1 and Th2 cytokines in autoimmune diseases. Autoimmunity 24(1):25-33. (Pubitemid 26379164)
49. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201(2):233-240. (Pubitemid 40189432)
50. Lee WW, Kang SW, Choi J, Lee SH, Shah K, Eynon EE, Flavell RA, Kang I. 2010. Regulating human Th17 cells via differential expression of IL-1 receptor. Blood 115(3):530-540.
51. Lira SA, Martin AP, Marinkovic T, Furtado GC. 2005. Mechanisms regulating lymphocytic infiltration of the thyroid in murine models of thyroiditis. Crit Rev Immunol 25(4):251-262. (Pubitemid 43075958)
52. Lutz MB, Schuler G. 2002. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 23(9):445-449. (Pubitemid 35015188)
53. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441(7090):231-234.
54. Mannon PJ, Fuss IJ, Mayer L, Elson CO, Sandborn WJ, Present D, Dolin B, Goodman N, Groden C, Hornung RL, and others. 2004. Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med 351(20):2069-2079. (Pubitemid 39482500)
55. Marrack P, Kappler J, Kotzin BL. 2001. Autoimmune disease: why and where it occurs. Nat Med 7(8):899-905. (Pubitemid 32756426)
56. Martin AP, Coronel EC, Sano G, Chen SC, Vassileva G, Canasto-Chibuque C, Sedgwick JD, Frenette PS, Lipp M, Furtado GC, and others. 2004. A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21. J Immunol 173(8):4791-4798. (Pubitemid 39387758)
57. McLachlan SM, Nagayama Y, Rapoport B. 2005. Insight into Graves' hyperthyroidism from animal models. Endocr Rev 26(6):800-832. (Pubitemid 41428539)
58. Meriggioli MN, Sheng JR, Li L, Prabhakar BS. 2008. Strategies for treating autoimmunity: novel insights from experimental myasthenia gravis. Ann N Y Acad Sci 1132:276-282. (Pubitemid 351841366)
59. Mignon-Godefroy K, Brazillet MP, Rott O, Charreire J. 1995a. Distinctive modulation by IL-4 and IL-10 of the effector function of murine thyroglobulin-primed cells in "transfer-experimental autoimmune thyroiditis". Cell Immunol 162(2): 171-177.
60. Mignon-Godefroy K, Rott O, Brazillet MP, Charreire J. 1995b. Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT). Evidence for IL-10-enhanced cell death in EAT. J Immunol 154(12):6634-6643.
61. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765. (Pubitemid 32368050)
62. Morris GP, Chen L, Kong YC. 2003. CD137 signaling interferes with activation and function of CD4+CD25+ regulatory T cells in induced tolerance to experimental autoimmune thyroiditis. Cell Immunol 226(1):20-29. (Pubitemid 38121294)
63. Moser M, Murphy KM. 2000. Dendritic cell regulation of TH1-TH2 development. Nat Immunol 1(3):199-205.
64. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136(7):2348-2357. (Pubitemid 16136806)
65. Mosmann TR, Coffman RL. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7:145-173. (Pubitemid 19138011)
66. Murphy KM, Reiner SL. 2002. The lineage decisions of helper T cells. Nat Rev 2(12):933-944. (Pubitemid 37323214)
67. Nabozny GH, Kong YC. 1992. Circumvention of the induction of resistance in murine experimental autoimmune thyroiditis by recombinant IL-1 beta. J Immunol 149(3):1086-1092.
68. Nagayama Y, Mizuguchi H, Hayakawa T, Niwa M, McLachlan SM, Rapoport B. 2003. Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cyto-kine. J Immunol 170(7):3522-3527. (Pubitemid 36359218)
69. Nagayama Y, Saitoh O, McLachlan SM, Rapoport B, Kano H, Kumazawa Y. 2004. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm. Clin Exp Immunol 138(3):417-422. (Pubitemid 39573620)
70. Nakagawa T, Tsuruoka M, Ogura H, Okuyama Y, Arima Y, Hirano T, Murakami M. 2010. IL-6 positively regulates Foxp3+CD8+ T cells in vivo. Int Immunol 22(2):129-139.
71. Nanba T, Watanabe M, Inoue N, Iwatani Y. 2009. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease. Thyroid 19(5):495-501.
72. Nossal GJ. 1996. Clonal anergy of B cells: a flexible, reversible, and quantitative concept. J Exp Med 183(5):1953-1956. (Pubitemid 26158886)
73. O'Shea JJ, Ma A, Lipsky P. 2002. Cytokines and autoimmunity. Nat Rev Immunol 2(1):37-45. (Pubitemid 37328774)
74. O'Sullivan BJ, Thomas HE, Pai S, Santamaria P, Iwakura Y, Steptoe RJ, Kay TW, Thomas R. 2006. IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J Immunol 176(12):7278-7287. (Pubitemid 43849028)
75. Patibandla SA, Fan JL, Prabhakar BS, Seetharamaiah GS. 1999. Comparison of immune responses to extracellular domains of mouse and human thyrotropin receptor. J Autoimmunity 13(2):205-213. (Pubitemid 29436135)
76. Patibandla SA, Wagle NM, Seetharamaiah GS, Fan JL, Dallas JS, Prabhakar BS. 1996. Experimental autoimmunity to thyrotro-pin receptor. Exp Clin Endocrinol Diabetes 104 Suppl 3:28-32.
77. Pichurin P, Yan XM, Farilla L, Guo J, Chazenbalk GD, Rapoport B, McLachlan SM. 2001. Naked TSH receptor DNA vaccination: A TH1 T cell response in which interferon-gamma production, rather than antibody, dominates the immune response in mice. Endocrinology 142(8):3530-3536. (Pubitemid 32681761)
78. Prabhakar BS, Bahn RS, Smith TJ. 2003. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev 24(6):802-835. (Pubitemid 38067700)
79. Sakaguchi S, Wing K, Miyara M. 2007. Regulatory T cells-a brief history and perspective. Eur J Immunol 37 Suppl 1:S116-S123. (Pubitemid 350131275)
80. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. 2008. Regulatory T cells and immune tolerance. Cell 133(5):775-787. (Pubitemid 351707693)
81. Schwartz RH. 2005. Natural regulatory T cells and self-tolerance. Nat Immunol 6(4):327-330. (Pubitemid 41716768)
82. Seetharamaiah GS, Fan JL, Patibandla SA, Prabhakar BS. 1996. Influence of adjuvants on the induction of autoanti-bodies to the thyrotropin receptor. Autoimmunity 24(4): 205-215. (Pubitemid 27086930)
83. Sharma R, Sung SS, Abaya CE, Ju AC, Fu SM, Ju ST. 2009. IL-2 regulates CD103 expression on CD4+ T cells in Scurfy mice that display both CD103-dependent and independent inflammation. J Immunol 183(2):1065-1073.
84. Sheng JR, Li L, Ganesh BB, Vasu C, Prabhakar BS, Meriggioli MN. 2006. Suppression of experimental autoimmune myas-thenia gravis by granulocyte-macrophage colony-stimulating factor is associated with an expansion of FoxP3+ regulatory T cells. J Immunol 177(8):5296-5306. (Pubitemid 44527602)
85. Sheng JR, Li LC, Ganesh BB, Prabhakar BS, Meriggioli MN. 2008. Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis. Clin Immunol 128(2):172-180.
86. Sheng JR, Li LC, Prabhakar BS, Meriggioli MN. 2009. Acet-ylcholine receptor-alpha subunit expression in myasthenia gravis: a role for the autoantigen in pathogenesis? Muscle Nerve 40(2):279-286.
87. Shi Y, Wang H, Su Z, Chen J, Xue Y, Wang S, Xue Y, He Z, Yang H, Zhou C, and others. 2010. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto's thyroiditis. Scand J Immunol 72(3):250-255.
88. Silva LC, Ortigosa LC, Benard G. 2010. Anti-TNF-alpha agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls. Immunotherapy 2(6):817-833.
89. Stassi G, De Maria R. 2002. Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev 2(3):195-204. (Pubitemid 37328766)
90. Stassi G, Di Liberto D, Todaro M, Zeuner A, Ricci-Vitiani L, Stoppacciaro A, Ruco L, Farina F, Zummo G, De Maria R. 2000. Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins. Nat Immunol 1(6):483-488.
91. Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31(2):331-341.
92. Tang H, Mignon-Godefroy K, Meroni PL, Garotta G, Charreire J, Nicoletti F. 1993. The effects of a monoclonal antibody to interferon-gamma on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells. Eur J Immunol 23(1):275-278. (Pubitemid 23031928)
93. Tang H, Sharp GC, Peterson KP, Braley-Mullen H. 1998. IFN-gamma-deficient mice develop severe granulomatous experimental autoimmune thyroiditis with eosinophil infiltration in thyroids. J Immunol 160(10):5105-5112. (Pubitemid 28215349)
94. Tomer Y. 2010. Hepatitis C and interferon induced thyroiditis. J Autoimmunity 34(3):J322-J326.
95. Tomer Y, Ban Y, Concepcion E, Barbesino G, Villanueva R, Greenberg DA, Davies TF. 2003. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 73(4):736-747. (Pubitemid 37271879)
96. Tourneur L, Damotte D, Marion S, Mistou S, Chiocchia G. 2002. IL-10 is necessary for FasL-induced protection from experimental autoimmune thyroiditis but not for FasL-induced immune deviation. Eur J Immunol 32(5):1292-1299. (Pubitemid 34546256)
97. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L. 1995. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 181(2):817-821.
98. Vasu C, Dogan RN, Holterman MJ, Prabhakar BS. 2003. Selective induction of dendritic cells using granulocyte macrophage-colony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4 +/CD25+ T cells and suppresses experimental autoimmune thyroiditis. J Immunol 170(11):5511-5522. (Pubitemid 36617839)
99. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24(2):179-189. (Pubitemid 43214587)
100. Verginis P, Li HS, Carayanniotis G. 2005. Tolerogenic semi-mature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4 + CD25+ T cells. J Immunol 174(11):7433-7439. (Pubitemid 40705715)
101. Vladutiu AO, Sulkowski E. 1980. Inhibition of murine autoimmune thyroiditis by interferon. Biomedicine 33(6):173-174. (Pubitemid 11140508)
102. Vural P, Degirmencioglu S, Erden S, Gelincik A. 2009. The relationship between transforming growth factor-beta1, vascular endothelial growth factor, nitric oxide and Hashimoto's thyroiditis. Int Immunopharmacol 9(2):212-215.
103. Wang SH, Bretz JD, Phelps E, Mezosi E, Arscott PL, Utsugi S, Baker JR Jr. 2002. A unique combination of inflammatory cy-tokines enhances apoptosis of thyroid follicular cells and transforms nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis. J Immunol 168(5):2470-2474. (Pubitemid 34171852)
104. Wang SH, Chen GH, Fan Y, Van Antwerp M, Baker JR Jr. 2009. Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells. Endocrinology 150(4): 2000-2007.
105. Weetman AP. 2003. Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 148(1):1-9. (Pubitemid 36175997)
106. Yanaba K, Bouaziz JD, Matsushita T, Magro CM, St Clair EW, Tedder TF. 2008. B-lymphocyte contributions to human autoimmune disease. Immunol Rev 223:284-299. (Pubitemid 351986191)
107. Yang J, Murphy TL, Ouyang W, Murphy KM. 1999. Induction of interferon-gamma production in Th1 CD4+ T cells: evidence for two distinct pathways for promoter activation. Eur J Immunol 29(2):548-555. (Pubitemid 29078515)
108. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, Dong C. 2007. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 282(13):9358-9363. (Pubitemid 47104613)
109. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, Akira S, Nakanishi K. 1998. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 161(7):3400-3407.
110. Yu S, Fang Y, Sharp GC, Braley-Mullen H. 2010. Transgenic expression of TGF-beta on thyrocytes inhibits development of spontaneous autoimmune thyroiditis and increases regulatory T cells in thyroids of NOD.H-2h4 mice. J Immunol 184(9): 5352-5359.
111. Zhang W, Kong YC. 1998. Noninvolvement of IL-4 and IL-10 in tolerance induction to experimental autoimmune thyroiditis. Cell Immunol 187(2):95-102. (Pubitemid 28397327)
112. Zhang ZL, Lin B, Yu LY, Shen SX, Zhu LH, Wang WP, Guo LH. 2003. Gene therapy of experimental autoimmune thyroiditis mice by in vivo administration of plasmid DNA coding for human interleukin-10. Acta Pharmacol Sinica 24(9):885-890.
113. Zheng W, Flavell RA. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89(4):587-596. (Pubitemid 27511769)
114. Zheng Y, Rudensky AY. 2007. Foxp3 in control of the regulatory T cell lineage. Nature Immunol 8(5):457-462. (Pubitemid 46605910)
115. Zhou L, Littman DR. 2009. Transcriptional regulatory networks in Th17 cell differentiation. Current Opin Immunol 21(2):146-152.
116. Ziegler SF, Buckner JH. 2009. FOXP3 and the regulation of Treg/Th17 differentiation. Microbes Infect 11(5):594-598.
117. Zipris D, Greiner DL, Malkani S, Whalen B, Mordes JP, Rossini AA. 1996. Cytokine gene expression in islets and thyroids of BB rats. IFN-gamma and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats. J Immunol 156(3):1315-1321.